Abstract:Background: Ovarian epithelial tumors include benign lesions lacking invasive and metastatic abilities (cystadenomas) in addition to malignant lesions (carcinomas). An intermediate category, called tumors of low malignant potential (LMP), is also recognized. The merit of this classification is being challenged because the clinical behavior of LMP tumors appears closer to that of cystadenomas than to that of carcinomas. Purpose: To verify our hypothesis that the expression of the enzyme telomerase distinguishes these two categories of ovarian epithelial tumors, we examined and compared such expression in ovarian cystadenomas and carcinomas. By examining the expression of telomerase in LMP tumors, we then sought to determine if these tumors were more closely related to cystadenomas or to carcinomas with regard to telomerase expression. Methods: We examined a total of 64 consecutive ovarian tumors subdivided into 20 carcinomas, 17 LMP tumors, and 27 cystadenomas. We subsequently discarded three of the 27 cystadenomas because of the presence of admired normal ovarian stroma in those specimens. Tumor subtyping was done without knowledge of the telomerase results, and telomerase assays were likewise interpreted without knowledge of tumor types. Telomerase activity was determined by use of the TRAP (i.e., telomeric repeat amplification protocol) assay. Differences between the proportions of tumors expressing this enzyme in each subgroup were evaluated by use of Fisher's exact test (two-sided). Results: Telomerase activity was detected in all 20 carcinomas and in all 17 LMP tumors examined. In contrast, it was not detected in 19 of the 24 cystadenomas. These differences between rates of telomerase expression in either carcinomas or LMP tumors and those in cystadenomas were statistically significant (P<.0001). All five of the telomerase-positive cystadenomas belonged to a variant called papillary cystadenomas, whereas none of the telomerase-negative cystadenomas belonged to this variant (P<.0001). Conclusions and Implications: The presence of telomerase expression in ovarian LMP tumors supports the merit of continuing to separate these tumors from cystadenomas, in spite of their apparent benign clinical course. The finding of telomerase expression in papillary cystadenomas suggests that such tumors may be mechanistically related to LMP tumors and should perhaps be reclassified as variants of LMP tumors. Lack of telomerase expression in ovarian cystadenomas raises questions about the alleged immortality of these tumors because expression of this enzyme is thought to be essential for continuous growth in adult tumors.

Study of Relationship Between Telomerase Activity and Expression of Bcl-2 and P53 Proteins in Human Ovarian Epithelial Tumors

Expression and clinical significance of P16, P15,and VEGF proteins in primary epithelial ovarian carcinoma

The Expression and Significance of BCL-2, BAX and P53 Proteins in Epithelial Ovarian Cancer

Expression of Telomerase Activity and Its Relationship with Clinical-Pathological Factors in Epithelial Ovarian Tumors

Correlation Study of Telomerase Activity and Expression of Htert Mrna in Patients with Ovarian Tumor

Telomerase activity in benign and malignant epithelial ovarian tumors.

Expression of p53、bcl-2 and c-erbB-2 in epithelial ovarian tumor and clinical effect

Study on the Expression of Telomerase and C-Erbb-2 in Ovarian Epithelial Tumor

[Expression of Telomerase and Telomerase Associated-Regulation Protein and Proliferating Cell Nuclear Antigen in Ovarian Epithelial Tumors].

[Relationship Between Expressions of P53, C-Erbb2 Genes, Proliferating Cell Nuclear Antigen and Prognosis of Patients with Ovarian Epithelial Carcinoma].

Clinical Significance and Prognostic Value of Extracellular Signal-Regulated Kinases in Epithelial Ovarian Cancer

Expression of PTEN and P-Akt Protein and Their Relationship with Clinical Features of Epithelial Ovarian Cancer

Experssion of Beclin1 and PTEN Protein and Their Relationship with Clinic Characteristic of Epithelial Ovarian Cancer

The Activity of Telomerase and Expression of C-myc Gene in Ovarian Tumors

The Telomerase Activity and Expression of Htert Gene Can Serve As Indicators in the Anti-Cancer Treatment of Human Ovarian Cancer.

Loss of P53 Gene and Amplification of HER-2 Oncogene and Their Clinical Significance in Epithelial Ovarian Carcinomas

Expressions of P73 Protein,p21~(waf1/cip1) Protein and PCNA Protein in Epithelial Ovarian Cancer and Their Correlation

Immunoexpression and Prognostic Role of P53 in Different Subtypes of Epithelial Ovarian Carcinoma

Investigation on the relationship between VEGF-C and p53 expression in ovarian epithelial tumors

Expression of HER-2 and TOPO- Ⅱα in Ovarian Epithelial Cancer and Its Clinical Significance

Related Investigation of Telomerase Genes and P53,bcl-2 Genes Expression in Breast Ductal Cancer and Precancerous Lession